Learn about LIBTAYO® (cemiplimab-rwlc) in the treatment of advanced NSCLC, BCC, CSCC, & as an adjuvant treatment for high-risk CSCC. Review Important Safety Info & Full Prescribing Information …

Learn about LIBTAYO® (cemiplimab-rwlc) for the treatment of advanced CSCC. Review Important Safety Info & Full Prescribing Information including Med Guide.

LIBTAYO, an immunotherapy, may help with certain kinds of cancer. LIBTAYO is a treatment that works by blocking cancer cells from binding with PD-1. This enables T cells to detect cancer cells and …

LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) that: Cannot be removed by surgery (locally advanced BCC) or when it has spread …

Patient examples from LIBTAYO trials Below are examples of 3 patients with locally advanced BCC previously treated with an HHI, who saw tumors shrink (partial response) with treatment. In this trial, …

LIBTAYO resources Get more information about LIBTAYO and how it may be an appropriate treatment option for your advanced cutaneous squamous cell carcinoma (CSCC). LIBTAYO downloadable …

The treatment options for NSCLC are based mainly on the stage and extent of the cancer. Other factors, such as your overall health and lung function, as well as certain traits of the cancer itself, are also …

LIBTAYO tools for patients & caregivers LIBTAYO resources Get more information about LIBTAYO and how it may be an appropriate treatment option for your advanced NSCLC.

Meaningful stories. Meaningful hope. It can be helpful and inspiring to hear the experiences of people living with advanced CSCC and their treatment with LIBTAYO. LIBTAYO is a prescription medicine …

LIBTAYO as a single agent is indicated for the first-line treatment of adult patients with NSCLC whose tumors have high PD-L1 expression [Tumor Proportion Score (TPS) ≥ 50%] as determined by an …